In light of the current COVID-19 pandemic, the ACR has dedicated a few episodes of the ACR on Air podcast to the challenges that have arisen, along with information about the available resources and guidance.
The first episode in this special series looks at drug shortages surrounding hydroxychloroquine (HCQ) and its initial uses to treat the coronavirus. In this episode, the host talks with ACR President-Elect David Karp, MD, PhD, and Amanda Grimm Wiegrefe, ACR director of regulatory affairs.
The series continues with a discussion on how to keep your practice going during the pandemic. Our host chats with Chris Phillips, MD, who runs a solo practice in Kentucky, and Dan Redinger, ACR manager of advocacy and political affairs, who is keeping his eye on the federal COVID-19 stimulus package. The guests share best practices and tips for healthcare providers during this unprecedented time.
In the midst of the COVID‑19 pandemic, rheumatologists and rheumatology professionals have found themselves in an unprecedented situation in which the rise of telehealth has been key to treating their patients. In the next episode of the series, the host speaks with two experts, Jay Mehta, MD, MS, the Children’s Hospital of Philadelphia, and Antanya Chung, ACR director of practice management, about telehealth best practices.
Experiencing COVID-19-related drug shortages, practice issues or any other problems? Send your comments and questions to COVID@rheumatology.org.